Stock Events

Stock Events

Merrimack Pharmaceuticals (MACK) Q3 2023 Earnings

2NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.03

-0.03

-0.02

-0.02

Details

Expected EPS

N/A

Actual EPS

-0.02

Surprise EPS

-0.02

Surprise Percent

+∞%

Description

Merrimack Pharmaceuticals (MACK) has reported earnings of -0.02 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.